The K-M survival curve analyses of 128 patients with prostate cancer showed that high-CKMT1B expression slightly reduced the PSA recurrence-free survival rate compared with patients with weak to moderate CKMT1B expression. The gene discussed is CKMT1B; the disease is prostate carcinoma.